Illustration of Rheum palmatum fighting liver cancer cells, highlighting the STAT3 pathway.

Beyond the Hype: Can a Traditional Herb Really Fight Liver Cancer?

Soraya Malik monogram
Soraya Malik in Health & Wellness October 2026 • 5 min read.

"Scientists Uncover Promising Anti-Cancer Properties of Rheum palmatum Extract"


In the relentless pursuit of combating cancer, scientists are constantly seeking new and effective treatments. Liver cancer, a formidable foe, demands innovative approaches, and the spotlight is now on a traditional Chinese herb: Rheum palmatum. This ancient remedy, often used in traditional medicine, is showing promising signs of potential as an anti-cancer agent.

This article delves into the fascinating findings of a recent study that explores the anti-cancer properties of Rheum palmatum extract. We'll uncover how this extract works at a cellular level, the impact it has on liver cancer cells, and what this means for the future of cancer treatment. Prepare to be informed and intrigued as we navigate the complexities of this groundbreaking research.

Join us on a journey of scientific discovery. We'll explore the research, the implications, and the hope that Rheum palmatum brings to the fight against liver cancer. Whether you're a health enthusiast, a science aficionado, or simply curious, this article promises an enlightening and engaging read.

AI Search Multiple angles on this topic

A Research Question, Not a Proven Treatment

Interest in traditional herbs as possible tools against liver cancer continues to grow, but the available evidence does not establish that any herb can replace proven cancer care. Claims about benefit should therefore be treated cautiously until supported by well-designed clinical studies. Patients should not delay diagnosis or standard treatment while pursuing unproven herbal remedies.

Standardization and Processing Challenges

Research on Rheum palmatum L. has examined how drying methods and processing modes affect physicochemical qualities and anthraquinone content. Another study compared fourteen preservation methods for R. palmatum leaves, including storage at -80°C, silica-gel desiccation, drying at 60°C, and ethanol-based preservation, using DNA extraction quality as an outcome. ISO 5228:2023 applies to Rheum root and rhizome sold as natural medicines in international trade, including whole materials and decoction pieces, but it does not cover processing methods or processed products. Together, these sources indicate that preparation and preservation can complicate efforts to produce consistent herbal materials.

From Dahuang to Modern Phytochemistry

Rheum palmatum is a perennial flowering plant in the Polygonaceae, or knotweed, family and is commonly known as Chinese rhubarb, ornamental rhubarb, Turkey rhubarb, and East Indian rhubarb. In Mandarin Chinese it is called dahuang, meaning “great yellow” or “big yellow,” a name associated with its large, yellowish medicinal rootstocks. The plant has long been used in traditional medicine and is also known for producing anthraquinones such as emodin and rhein. These compounds have been reported to show antiviral effects, although that finding does not establish an anticancer effect in humans.

Unpacking the Science: How Rheum palmatum Fights Liver Cancer

Illustration of Rheum palmatum fighting liver cancer cells, highlighting the STAT3 pathway.

The recent study, published in the Journal of Ethnopharmacology, provides compelling evidence of Rheum palmatum extract's anti-cancer activity. The research team discovered that the extract works by inhibiting the signal transducer and activator of transcription 3 (STAT3) signaling pathway. This pathway plays a significant role in the growth and spread of cancer cells. By disrupting this pathway, the extract effectively targets and hinders cancer cells.

The study's findings are particularly exciting because they shed light on how this traditional herb directly impacts liver cancer cells. Researchers found that the extract reduced the viability of liver cancer cells, essentially slowing down their growth. Additionally, the extract triggered apoptosis, or programmed cell death, in these cells. This dual-action approach, combined with the extract's ability to inhibit angiogenesis (the formation of new blood vessels that feed tumors), highlights its multifaceted anti-cancer potential.

  • Reduced Cell Viability: The extract decreased the growth and survival of liver cancer cells.
  • Induced Apoptosis: The extract triggered programmed cell death in cancer cells.
  • Inhibited Angiogenesis: The extract curbed the formation of new blood vessels that feed tumors.
  • Reduced Metastasis: The extract decreased the migration and invasion of cancer cells.
  • Suppressed Key Proteins: The extract lowered the levels of proteins like Cyclin D1, CDK4, and c-Myc, which are essential for cancer cell growth and survival.
AI Search Multiple angles on this topic

Evidence Remains Limited

Current research on Rheum palmatum spans chemical profiling, laboratory activity, and reviews of possible therapeutic uses. However, the sources provided here do not establish that R. palmatum treats liver cancer in patients. Any anticancer interpretation should therefore remain preliminary until directly tested in appropriately designed clinical research.

Promising Signals Are Not Proof

Laboratory or traditional-use findings alone cannot demonstrate that Rheum palmatum improves liver-cancer survival, tumor control, or quality of life. Herbal preparations may also vary according to plant material, preservation, processing, and chemical composition. Without direct clinical evidence for liver cancer, claims of a reliable treatment remain unconfirmed.

Different Evidence Categories

Rheum palmatum research includes plant chemistry, preservation studies, traditional-medicine applications, and clinical reviews in conditions other than liver cancer. These forms of evidence answer different questions and should not be treated as interchangeable. In particular, evidence concerning other diseases or laboratory effects cannot by itself establish comparative effectiveness against accepted liver-cancer treatments.

The study's implications extend beyond laboratory results. The researchers also explored the effects of Rheum palmatum extract in a xenograft tumor nude mouse model of HCC. In these mice, the extract significantly reduced tumor growth, further reinforcing its anti-cancer potential. This in vivo evidence adds another layer of credibility to the extract's potential as a therapeutic agent for liver cancer. These findings have paved the way for further research and potential clinical trials, bringing hope to those affected by this devastating disease.

A Glimmer of Hope: The Future of Liver Cancer Treatment

The research on Rheum palmatum offers a beacon of hope in the fight against liver cancer. With its promising anti-cancer effects, this traditional herb has the potential to be a significant therapeutic agent. While more research is needed, the initial findings are encouraging, suggesting that Rheum palmatum could be a valuable addition to the arsenal of treatments for this devastating disease. This is an exciting time for cancer research, and we eagerly anticipate the next steps in this promising journey. This article offers information and insights that are for informational purposes only and should not be considered medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.

AI Search Multiple angles on this topic

Potential Requires Safety and Clinical Proof

The evidence portrays Rheum palmatum as a chemically diverse medicinal plant, not as a proven liver-cancer therapy. A study of seven extracts used pressurized solvent extraction, nuclear magnetic resonance profiling, and tyrosinase-inhibition testing, illustrating the effort required to characterize different preparations. Separately, an EFSA scientific opinion examined the safety of plant preparations from the root or rhizome of Rheum palmatum, Rheum officinale, and their hybrids, among other plants under Union scrutiny. Reviews of randomized trials have also examined R. palmatum for acute lung injury and acute respiratory distress syndrome, rather than liver cancer. These findings support continued investigation but do not justify presenting the herb as an established cancer treatment.

A Growing Extract Market

Commercial forecasts suggest increasing interest in Rheum rhaponticum root extract and related herbal products. One market report cites an expected global herbal supplement market value of USD 100 billion by 2025, while another projects the Rheum rhaponticum root extract market to grow at a 7.2% compound annual growth rate from an estimated USD 84.13 million valuation by 2033. These are market projections, not evidence of clinical benefit. Future research should distinguish commercial expansion from demonstrated safety and effectiveness.

Genetic and Chemical Diversity

Recent population studies suggest that the Rheum palmatum complex is not uniform. A 2025 transcriptomic and metabolomic analysis identified three distinct lineages within the complex, while another study reported genetic diversity and moderate differentiation among R. palmatum populations in a top-geoherb area. RNA-seq-derived single-nucleotide polymorphism datasets may help trace the geographic origins of core germplasm. Such variation can make it harder to assume that products labeled with the same plant name have identical chemical profiles or biological effects.

Research Beyond Cancer

Studies of Rheum palmatum describe possible applications outside liver cancer. One investigation evaluated Rheum palmatum root extract with Aloe vera for fibroblast migration and antibacterial activity against P. gingivalis in the context of oral tissue regeneration and inflammation. Another used network pharmacology and animal experiments to examine a Rheum palmatum and Salvia miltiorrhiza combination for acute pancreatitis. A review collected randomized controlled trials of R. palmatum for acute lung injury and acute respiratory distress syndrome, while a 2024 review emphasized the need for more research into the plant’s mechanisms and medicinal uses. These findings show active investigation but do not demonstrate benefit for people with liver cancer.

What rhubarb-related findings mean for liver cancer

STAT3 is associated with several cancer-cell behaviors, but its role can vary with the disease context. A review notes that it may act against cancer in some forms of liver cancer, so suppressing this pathway cannot be assumed to have the same effect in every case.[1] [2]

An extract’s chemical profile and the activity of an isolated compound answer different questions. Findings about emodin in liver-cancer cells do not by themselves establish how a complex root extract behaves.[3] [4]

Apoptosis is not automatically evidence of a cancer-specific benefit: emodin-induced cell damage is also discussed in relation to liver toxicity. The reported effects therefore need to be interpreted alongside potential harm to liver cells.[5]

How the extract fits beside related evidence

A review describes STAT3 as commonly activated in human cancers, while another reported that sustained Src inhibition could activate STAT3 and support cancer-cell survival. Together, these observations illustrate that pathway effects may depend on the biological setting, rather than being uniformly beneficial when inhibited.[6] [7]

A rat investigation set out to test methanol extract of Rheum palmatum roots against chemically induced liver cancer and to characterize its constituents. This is a different evidence setting from emodin experiments in HepG2 cells, and neither design alone establishes effects in patients.[3] [4]

A review of Rheum species describes multiple signaling pathways as possible parts of their anticancer activity. This broader mechanistic picture cautions against treating STAT3 as the only relevant explanation for effects attributed to rhubarb.[8]

What remains unresolved about Rheum palmatum

  • Do the reported pathway effects persist across different extract preparations, given that root extracts are chemically profiled as mixtures of secondary metabolites?[4]
  • How do the potential anticancer effects balance against liver, kidney, or gastrointestinal harms reported for rhubarb components and anthraquinones?[5] [9]
  • Can results from experimental cancer models predict outcomes in people, given the stated limitations of cell cultures and the rat-model research context?[4] [10]

Terms used in the evidence

STAT3
Signal transducer and activator of transcription 3.[1] [2]

Sources

  1. STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma (pmc.ncbi.nlm.nih.gov)
  2. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. (doi.org, 2019)
  3. Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma (pmc.ncbi.nlm.nih.gov)
  4. Rheum palmatum root extract inhibits hepatocellular carcinoma in rats treated with diethylnitrosamine. (pubmed.ncbi.nlm.nih.gov)
  5. Advances in the mechanism of emodin-induced hepatotoxicity (pmc.ncbi.nlm.nih.gov)
  6. Effect of signal transducer and activator of transcription 3 in neoplasms invasion and metastasis (International Journal of Stomatology, 2010)
  7. Faculty Opinions recommendation of Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding. (Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2009)
  8. Unveiling the cancer-fighting potential of Rheum species (Rhubarb): Phytochemistry, ethnopharmacology, and mechanistic insights into the anticancer effects of key anthraquinones (Phytomedicine Plus, 2025)
  9. Ultra-performance liquid chromatography-quadrupole\time-of- flight mass spectrometry with multivariate statistical analysis for exploring potential chemical markers to distinguish between raw and proc (pmc.ncbi.nlm.nih.gov)
  10. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.jep.2018.12.019, Alternate LINK

Title: Rheum Palmatum Extract Exerts Anti-Hepatocellular Carcinoma Effects By Inhibiting Signal Transducer And Activator Of Transcription 3 Signaling

Subject: Drug Discovery

Journal: Journal of Ethnopharmacology

Publisher: Elsevier BV

Authors: Zhang-Bin Tan, Hui-Jie Fan, Yu-Ting Wu, Ling-Peng Xie, Yi-Ming Bi, Hong-Lin Xu, Hong-Mei Chen, Jun Li, Bin Liu, Ying-Chun Zhou

Published: 2019-03-01

Everything You Need To Know

1

What is Rheum palmatum and why is it being researched in relation to liver cancer?

Rheum palmatum is a traditional Chinese herb that has been used in traditional medicine for various ailments. Recent research has focused on its potential anti-cancer properties, particularly its effects on liver cancer cells. Scientists are exploring how Rheum palmatum extract can impact the growth and spread of liver cancer.

2

How does Rheum palmatum extract work to fight liver cancer at a cellular level?

Research indicates that Rheum palmatum extract inhibits the signal transducer and activator of transcription 3 (STAT3) signaling pathway, which is crucial for cancer cell growth. By disrupting the STAT3 pathway, the extract effectively hinders the proliferation of liver cancer cells. Additionally, it can reduce cell viability, induce apoptosis (programmed cell death), and inhibit angiogenesis, which is the formation of new blood vessels that feed tumors.

3

What specific effects did Rheum palmatum extract have on liver cancer cells in the study?

In the study, Rheum palmatum extract demonstrated multiple beneficial effects on liver cancer cells. It reduced cell viability, slowing down the growth of cancer cells. The extract also induced apoptosis, triggering programmed cell death in these cells. Furthermore, it inhibited angiogenesis, preventing the formation of new blood vessels that tumors need to grow. Additionally, the extract decreased the migration and invasion of cancer cells reducing metastasis. The study also showed the extract lowered the levels of proteins like Cyclin D1, CDK4, and c-Myc, which are essential for cancer cell growth and survival.

4

What are the implications of Rheum palmatum extract suppressing proteins like Cyclin D1, CDK4 and c-Myc in relation to liver cancer treatment?

The suppression of proteins such as Cyclin D1, CDK4, and c-Myc by Rheum palmatum extract holds significant implications for liver cancer treatment. These proteins are vital for cancer cell growth and survival, acting as key regulators in cell cycle progression and proliferation. By lowering the levels of these proteins, Rheum palmatum extract can effectively inhibit the uncontrolled growth of liver cancer cells, potentially leading to tumor regression or stabilization. This targeted approach offers a promising avenue for developing more effective and less toxic therapies for liver cancer, by disrupting the fundamental mechanisms that drive cancer cell proliferation.

5

Beyond laboratory studies, is there any evidence of Rheum palmatum's effectiveness in living organisms regarding liver cancer?

Yes, the study extended its investigation beyond laboratory cell cultures. Researchers explored the effects of Rheum palmatum extract in a xenograft tumor nude mouse model of HCC (hepatocellular carcinoma). In these mice, the extract significantly reduced tumor growth. This in vivo evidence provides stronger support for Rheum palmatum's potential as a therapeutic agent for liver cancer, as it demonstrates effectiveness in a living organism. Such findings increase the likelihood of future clinical trials and the potential development of new treatments.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.